Martin P. Sutter - Nov 15, 2022 Form 4 Insider Report for ABIOMED INC (NASD)

Role: Director
Signature: /s/ Marc A Began (by power of attorney)
Stock symbol: NASD
Transactions as of: Nov 15, 2022
Transactions value $: -$1,498,458
Form type: 4
Date filed: 11/17/2022, 03:05 PM
Previous filing: Aug 17, 2022
Next filing: Dec 27, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NASD	Common Stock, $0.01 par value	Sale	-$424K	-1.13K	-0.92%	$374.18^*	122K	Nov 15, 2022	Direct	F1, F2
transaction	NASD	Common Stock, $0.01 par value	Sale	-$325K	-867	-0.71%	$374.92^*	121K	Nov 15, 2022	Direct	F1, F3
transaction	NASD	Common Stock, $0.01 par value	Sale	-$696K	-1.86K	-1.53%	$374.66^*	120K	Nov 16, 2022	Direct	F1, F4
transaction	NASD	Common Stock, $0.01 par value	Sale	-$53K	-141	-0.12%	$375.56^*	119K	Nov 16, 2022	Direct	F1, F5

Showing 1 to 4 of 4 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F2	This price represents the sale price of the transactions on the reported date at $374.1828. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F3	This price represents the sale price of the transactions on the reported date at $374.9239. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F4	This price represents the sale price of the transactions on the reported date at $374.6617. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F5	This price represents the sale price of the transactions on the reported date at $375.5611. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.